Pharmacokinetics of AZD7295 Capsules

Arrow Therapeutics

Status and phase: Completed; Phase 1

Conditions: Healthy

Treatments: Drug: Placebo comparator; Drug: AZD7295

Study type: Interventional

Funder types: Industry

Identifiers

NCT01097408

HCV689-105

Details and patient eligibility

About

This is a pharmacokinetics (PK) and safety study of AZD7295 in healthy volunteers.

Enrollment: 12 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy male or female volunteers, aged 18-65 years.

Exclusion criteria

• Previous exposure to AZD7295, clinically relevant disease.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

12 participants in 2 patient groups, including a placebo group

AZD7295

Experimental group

Treatment:

Drug: AZD7295

Matched placebo

Placebo Comparator group

Treatment:

Drug: Placebo comparator